A bipartisan group of lawmakers are set to introduce legislation to break up pharmacy-benefit managers, the drug middlemen that have now faced yearslong scrutiny from Congress and the Federal Trade Commission.
A companion bill, which sponsors say draws on a history of government prohibitions on joint ownership within industries, was also scheduled to be introduced in the House on Wednesday.
…
Read the full story here.